Focus:
Cardiovascular
-
27 November 2019 Deal News
Ardelyx and Kyowa Kirin expand drug development partnership
Kyowa Kirin has announced an expansion of its collaboration with specialised biotech Ardelyx regarding the latter’s novel cardiorenal-focused therapies.
-
18 November 2019 News
Promising results for Novartis’s Entresto in HFpEF sub-populations
Novartis has announced its heart failure drug Entresto (sacubitril/valsartan) causes a greater reduction in heart failure hospitalisation and cardiovascular (CV) deaths compared to valsartan alone in women with heart failure...
-
15 November 2019 News
Bayer to invest $100m for alliance with Dewpoint Therapeutics
Bayer has entered an option, research and licence agreement valued at approximately $100m with Dewpoint Therapeutics to develop therapies for cardiovascular and gynaecological conditions.
-
6 November 2019 Comment
AstraZeneca’s Farxiga continues to expand its therapeutic reach
AstraZeneca has targeted and continues to target multiple indications and related comorbidities to expand the therapeutic reach of Farxiga.
-
24 October 2019 Influencers
Cardiovascular: European Society of Cardiology tops Twitter Q3 2019
Pharmaceutical Technology lists the top five terms tweeted in cardiovascular in Q3 2019, based on data from GlobalData’s Influencer Platform.
-
22 October 2019 Comment
Cancer survivors are at increased risk of developing cardiovascular disease
Cardiovascular diseases are responsible for almost half of all deaths in the World Health Organization European region.
-
8 October 2019 Comment
Are we entering the era of novel inhaled phosphodiesterase inhibitors?
The inhaled PDE4 inhibitor showed a larger reduction of moderate to severe exacerbations in a subgroup of patients with chronic bronchitis.
-
27 September 2019 Analysis
Using a quadruple polypill to prevent major CV events
Although CV disease is the main cause of death globally, it is a particularly significant issue in developing countries where there are more challenges to accessing medication. One solution to...
-
17 September 2019 Comment
Smoke and mirrors: The complicated truth about vaping
There are at least 215 possible cases across 25 states where the development of severe lung disease has been linked to vaping.
-
13 September 2019 News
Penn researchers study cancer therapy in heart disease treatment
A research team from Penn Medicine at the University of Pennsylvania has been studying CAR T-cell therapy, which is used to fight cancer, in the treatment of heart disease.